Literature DB >> 14616794

Evidence for increased expression of regulatory cytokine receptors interleukin-12R and interleukin-18R in common variable immunodeficiency.

A McQuaid1, V J Tormey, B Trafford, A D Webster, M Bofill.   

Abstract

We investigated the expression of T helper (Th)1/Th2 regulatory cytokine receptors on lymphocytes from patients with common variable immunodeficiency (CVID), a disorder associated with raised Th1 cytokine production, comparing the results with those from healthy individuals and atopic asthmatics, the latter generally considered to have a Th2-driven disease. We proposed that alterations in some of the relevant receptors might be related to the observed imbalances in Th1/Th2 cytokines. Cells from CVID patients showed an increase in the percentages of CD212 [interleukin (IL)-12Rbeta1] cells within the CD4+ CD45RA+ and CD8+ CD45RA+ subsets (24% and 41%, respectively), as compared to CD4+ CD45RA+ and CD8+ CD45RA+ in healthy subjects (6% and 23%, respectivey). Approximately 21% of the CD4+ CD45RA+ naïve cells expressed IL-18Ralpha, compared with 11% in healthy subjects. In contrast, the cytokine-receptor expression in asthmatics was similar to that of controls. In spite of the above differences, after 72 h of stimulation with anti-CD3 and anti-CD28, cytokine receptor up-regulation was similar in all three groups, with up to 80% of both CD45RA+ and CD45RO+ lymphocytes expressing CD212 (IL-12Rbeta1) and IL-18Ralpha. Approximately 50% of the 'naïve', and 25% of the 'memory' subpopulations up-regulated IL-12Rbeta2. These findings provide further evidence of a polarization towards a Th1 immune response in CVID, the mechanism possibly involving up-regulation of IL-12-mediated pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616794      PMCID: PMC1808869          DOI: 10.1046/j.1365-2249.2003.02271.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency.

Authors:  D Bonhomme; L Hammarström; D Webster; H Chapel; O Hermine; F Le Deist; E Lepage; P H Romeo; Y Levy
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

2.  Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development.

Authors:  C A Wenner; M L Güler; S E Macatonia; A O'Garra; K M Murphy
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

3.  Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma.

Authors:  T C van der Pouw Kraan; L C Boeije; E R de Groot; S O Stapel; A Snijders; M L Kapsenberg; J S van der Zee; L A Aarden
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

4.  Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets.

Authors:  M E North; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

5.  Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex.

Authors:  D H Presky; L J Minetti; S Gillessen; V L Wilkinson; C Y Wu; U Gubler; R Chizzonite; M K Gately
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

6.  Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. MRC Immunodeficiency Group.

Authors:  I Kondratenko; P L Amlot; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1997-04       Impact factor: 4.330

7.  Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2.

Authors:  C M Hilkens; H Vermeulen; R J van Neerven; F G Snijdewint; E A Wierenga; M L Kapsenberg
Journal:  Eur J Immunol       Date:  1995-01       Impact factor: 5.532

8.  Interleukin-12 production by human polymorphonuclear leukocytes.

Authors:  M A Cassatella; L Meda; S Gasperini; A D'Andrea; X Ma; G Trinchieri
Journal:  Eur J Immunol       Date:  1995-01       Impact factor: 5.532

9.  Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.

Authors:  C E Verhagen; H H Smits; F A Verreck; E A Wierenga; M Kurimoto; D A Lammas; D S Kumararatne; O Sanal; F P Kroon; F Sinigaglia; T H Ottenhoff
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  Selective expression of an interleukin-12 receptor component by human T helper 1 cells.

Authors:  L Rogge; L Barberis-Maino; M Biffi; N Passini; D H Presky; U Gubler; F Sinigaglia
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

View more
  10 in total

1.  Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene.

Authors:  N Martinez-Pomar; S Raga; J Ferrer; J Pons; I Munoz-Saa; M-R Julia; J de Gracia; N Matamoros
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Differential expression of the cytokine receptors for human interleukin (IL)-12 and IL-18 on lymphocytes of both CD45RA and CD45RO phenotype from tonsils, cord and adult peripheral blood.

Authors:  M Bofill; E Almirall; A McQuaid; R Peña; R Ruiz-Hernandez; M Naranjo; L Ruiz; B Clotet; F E Borràs
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

3.  The T cell response to persistent herpes virus infections in common variable immunodeficiency.

Authors:  M Raeiszadeh; J Kopycinski; S J Paston; T Diss; M Lowdell; G A D Hardy; A D Hislop; S Workman; A Dodi; V Emery; A D Webster
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

Review 4.  Common variable immune deficiency: reviews, continued puzzles, and a new registry.

Authors:  Charlotte Cunningham-Rundles; Adina Kay Knight
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 5.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

6.  Monocyte derived dendritic cell responses in common variable immunodeficiency.

Authors:  T H Scott-Taylor; M R J Green; E Eren; A D B Webster
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

7.  Antigen-independent IFN-γ production by human naïve CD4 T cells activated by IL-12 plus IL-18.

Authors:  Rachel B Munk; Katsuki Sugiyama; Paritosh Ghosh; Carl Y Sasaki; Louis Rezanka; Kasturi Banerjee; Hidenori Takahashi; Ranjan Sen; Dan L Longo
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

8.  High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID).

Authors:  Barry R Zeeberg; Haiying Qin; Sudarshan Narasimhan; Margot Sunshine; Hong Cao; David W Kane; Mark Reimers; Robert M Stephens; David Bryant; Stanley K Burt; Eldad Elnekave; Danielle M Hari; Thomas A Wynn; Charlotte Cunningham-Rundles; Donn M Stewart; David Nelson; John N Weinstein
Journal:  BMC Bioinformatics       Date:  2005-07-05       Impact factor: 3.169

9.  IL-27-induced gene expression is downregulated in HIV-infected subjects.

Authors:  Christina Guzzo; Wilma M Hopman; Nor Fazila Che Mat; Wendy Wobeser; Katrina Gee
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

10.  Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages.

Authors:  Jing Qin Wu; Bin Wang; Larissa Belov; Jeremy Chrisp; Jenny Learmont; Wayne B Dyer; John Zaunders; Anthony L Cunningham; Dominic E Dwyer; Nitin K Saksena
Journal:  Retrovirology       Date:  2007-11-26       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.